Oragenics, Inc. (OGEN)

1,3800 +0,1700 (+14,05%) Börsenschluss: 03:59PM EDT

Oragenics, Inc.

4902 Eisenhower Boulevard
Suite 125
Tampa, FL 33634
United States
813 286 7900
https://www.oragenics.com

Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 5

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Charles L. Pope CPA	Executive Chairman	112,5k	N/A	1952
Mr. Joseph Michael Redmond	President & Interim Principal Executive Officer	N/A	N/A	1961
Ms. Janet Huffman	CFO, Secretary & Treasurer	314,9k	N/A	1972
Dr. James P. Kelly M.A., M.D.	Chief Medical Officer & Member of Scientific Advisor	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The company also develops NT-CoV2-1, a SARS-CoV-2 vaccine product candidate; and Lantibiotic Product Candidate, such as Mutacin 1140 (MU1140), a molecule belonging to the novel class of antibiotics. It has a license agreement with Inspirevax Inc. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida.

Corporate Governance

Oragenics, Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.